We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLN icon
801
PUT
iShares Global Clean Energy ETF
ICLN
$2.22B
$212K ﹤0.01%
10,000
RWM icon
802
ProShares Short Russell2000
RWM
$133M
$209K ﹤0.01%
+10,000
New +$208K
TMC icon
803
TMC The Metals Company
TMC
$1.49B
$208K ﹤0.01%
+100,000
New +$303K
QURE icon
804
uniQure
QURE
$2.78B
$207K ﹤0.01%
10,000
-13,500
-57% -$387K
CNX icon
805
CALL
CNX Resources
CNX
$4.91B
$206K ﹤0.01%
15,000
CVAC
806
PUT
DELISTED
CureVac
CVAC
$206K ﹤0.01%
+6,000
New +$241K
MCRB icon
807
CALL
Seres Therapeutics
MCRB
$45M
$200K ﹤0.01%
1,200
-1,435
-54% -$228K
ARRY icon
808
PUT
Array Technologies
ARRY
$740M
$196K ﹤0.01%
12,500
COCO icon
809
Vita Coco
COCO
$3.86B
$195K ﹤0.01%
+17,500
New +$223K
ITCI
810
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$194K ﹤0.01%
3,700
CNR
811
CALL
DELISTED
Cornerstone Building Brands, Inc.
CNR
$194K ﹤0.01%
+11,100
New +$172K
AGI icon
812
PUT
Alamos Gold
AGI
$12B
$192K ﹤0.01%
25,000
XOP icon
813
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$192K ﹤0.01%
+2,000
New +$205K
LAZR
814
PUT
DELISTED
Luminar Technologies
LAZR
$191K ﹤0.01%
753
-9,247
-92% -$2.31M
VRA icon
815
PUT
Vera Bradley
VRA
$98.7M
$191K ﹤0.01%
+22,500
New +$216K
B
816
CALL
Barrick Mining
B
$60.9B
$190K ﹤0.01%
10,000
B
817
PUT
Barrick Mining
B
$60.9B
$190K ﹤0.01%
10,000
NNDM
818
Nano Dimension
NNDM
$314M
$190K ﹤0.01%
50,000
EQT icon
819
PUT
EQT Corp
EQT
$32.9B
$188K ﹤0.01%
8,600
-5,800
-40% -$121K
VXRT
820
CALL
DELISTED
Vaxart
VXRT
$188K ﹤0.01%
30,000
SPOT icon
821
PUT
Spotify
SPOT
$108B
$187K ﹤0.01%
800
EMR icon
822
Emerson Electric
EMR
$81.6B
$186K ﹤0.01%
2,000
-4,250
-68% -$400K
GSM icon
823
FerroAtlántica
GSM
$590M
$185K ﹤0.01%
29,800
+26,000
+684% +$178K
COMP icon
824
PUT
Compass
COMP
$8.67B
$182K ﹤0.01%
20,000
AMBP icon
825
CALL
Ardagh Metal Packaging
AMBP
$2.96B
$181K ﹤0.01%
+20,000
New +$190K

Similar funds

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.